Prostate cancer is one of the most common forms of cancer that affects men. It is estimated that 1 in 9 men will be diagnosed with prostate cancer in their lifetime.

In the United States alone, it is estimated that there will be over 248,000 new cases of prostate cancer diagnosed in 2021. While there are several treatments available for prostate cancer, including surgery, chemotherapy, and radiation therapy, they are not always effective in treating the disease.

However, a new drug has been developed that may enhance the effectiveness of prostate cancer therapy. The drug is called enzalutamide, and it has been shown to improve the survival rates of men with advanced prostate cancer.

What is enzalutamide?

Enzalutamide is a type of hormone therapy that is used to treat prostate cancer. The drug blocks the effects of testosterone on prostate cancer cells, which can slow down the growth and spread of the cancer.

Enzalutamide is usually prescribed for men whose cancer has spread beyond the prostate gland, or who have undergone other treatments that have not been effective.

The drug is taken orally, usually as a capsule, and is typically used in combination with other treatments such as chemotherapy or radiation therapy.

How does enzalutamide enhance the effectiveness of prostate cancer therapy?

Studies have shown that enzalutamide can significantly improve the survival rates of men with advanced prostate cancer.

In a clinical trial conducted by the manufacturer of the drug, enzalutamide was shown to improve overall survival rates by 38% compared to a placebo. The drug was also found to delay the progression of the cancer, with a 76% decrease in the risk of the cancer progressing or spreading.

Enzalutamide works by targeting the androgen receptors on prostate cancer cells. These receptors are responsible for allowing testosterone to stimulate the growth and spread of prostate cancer cells.

Enzalutamide blocks these receptors, preventing testosterone from stimulating the cancer cells and slowing down the growth of the cancer.

Side effects of enzalutamide

As with any medication, enzalutamide can cause side effects. Some of the most common side effects of enzalutamide include:.

Hot flashes
Fatigue
Headaches
Nausea
Diarrhea
High blood pressure

Less common side effects of enzalutamide include an increased risk of heart attack or stroke, seizures, and falls. Patients should discuss any side effects with their doctor, who may recommend a different treatment or a change in dosage.

Conclusion

Enzalutamide is a promising new drug that can enhance the effectiveness of prostate cancer therapy. Studies have shown that the drug can improve survival rates and delay the progression of the cancer.

While enzalutamide can cause side effects, these are usually manageable and can be discussed with a doctor. As with any medication, patients should discuss the risks and benefits of enzalutamide with their doctor before beginning treatment.